Arbutus Biopharma Corporation ABUS Professional Service Fees Payable
Professional Service Fees Payable at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's professional service fees payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's professional service fees payable?
- Arbutus Biopharma Corporation (ABUS) reported professional service fees payable of $1.57M in Q1 2026.
- How has Arbutus Biopharma Corporation's professional service fees payable changed year-over-year?
- Arbutus Biopharma Corporation's professional service fees payable decreased by 29.8% year-over-year, from $2.24M to $1.57M.
- What is the long-term trend for Arbutus Biopharma Corporation's professional service fees payable?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's professional service fees payable has grown at a 9.6% compound annual growth rate (CAGR), from $679K to $1.08M.